Liang He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liang He has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Chao Zheng
Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, PR China
2 shared publications- Chunxi Wang
Department of Urology, The First Hospital of Jilin University, Changchun, China
2 shared publications Jixue Wang
Department of Urology, The First Hospital of Jilin University, Changchun, 130021, Jilin, China
2 shared publicationsShengxian Li
Department of Urology, First Hospital of Jilin University, Changchun, Jilin Province, China
2 shared publicationsAndrew K. Whittaker
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
1 shared publicationAnnan Liu
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in SSRN Electronic Journal
GRPR-targeted Iron Oxide Nanocarrier for Docetaxel Delivery and Ferroptosis-associated Synergistic Therapy in Prostate Cancer
Background: Prostate cancer (PCa) is one of the leading causes of cancer related mortality among men worldwide. Although docetaxel (DTX) is the standard chemotherapy for advanced PCa, its clinical efficacy is frequently limited by poor tumor selectivity, systemic toxicity, and therapeutic resistance. Ferroptosis is an iron- dependent form of regulated cell death characterized by the accumulation of excessive lipid peroxidation. Recently, ferroptosis induction has attracted increasing attention as a promising strategy to enhance tumor chemosensitivity. Methods: In this work, we developed a bombesin (BBN)-functionalized iron oxide DTX delivery nanoplatform (BBN-IONPs@DTX). These iron oxide nanoplatforms facilitate DTX delivery while serving as endogenous iron reservoirs to trigger ferroptosis through Fe²⁺/Fe³⁺ release. This strategy achieving combination of chemotherapy and ferroptosis therapy for PCa. BBN was employed for actively targeting to gastrin-releasing peptide receptor (GRPR)-overexpressing PCa cells. Furthermore, IONPs served as MRI-assisted imaging, drug carriers and ferroptosis inducers through intracellular Fe²⁺ release and Fenton reaction. The physicochemical properties, drug release behavior, cellular uptake, cytotoxicity, ferroptosis induction, MRI imaging performance, and anti-PCa efficacy were systematically evaluated in vitro and in vivo. Results: BBN-IONPs@DTX exhibited favorable physicochemical stability, efficient DTX loading, and accelerated drug release under acidic conditions. GRPR-mediated targeting significantly enhanced nanoparticle internalization in prostate cancer cells. Compared with free DTX or non-targeted IONPs, BBN-IONPs@DTX significantly inhibited tumor cell proliferation. Mechanistically, the nanoplatform induced excessive intracellular ROS generation, glutathione depletion, mitochondrial membrane depolarization, lipid peroxidation, and GPX4 downregulation, indicating enhanced ferroptosis. In vivo, BBN-IONPs@DTX achieved superior tumor accumulation and significantly suppressed tumor growth. Conclusion: The BBN-IONPs@DTX nanoplatform integrates active GRPR targeting, chemotherapy, and ferroptosis induction into a single therapeutic system, providing an effective strategy for synergistic treatment of PCa.
- 1 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGRPR-targeted Iron Oxide Nanocarrier for Docetaxel Delivery and Ferroptosis-associated Synergistic Therapy in Prostate Cancer
Background: Prostate cancer (PCa) is one of the leading causes of cancer related mortality among men worldwide. Although docetaxel (DTX) is the standard chemotherapy for advanced PCa, its clinical efficacy is frequently limited by poor tumor selectivity, systemic toxicity, and therapeutic resistance. Ferroptosis is an iron- dependent form of regulated cell death characterized by the accumulation of excessive lipid peroxidation. Recently, ferroptosis induction has attracted increasing attention as a promising strategy to enhance tumor chemosensitivity. Methods: In this work, we developed a bombesin (BBN)-functionalized iron oxide DTX delivery nanoplatform (BBN-IONPs@DTX). These iron oxide nanoplatforms facilitate DTX delivery while serving as endogenous iron reservoirs to trigger ferroptosis through Fe²⁺/Fe³⁺ release. This strategy achieving combination of chemotherapy and ferroptosis therapy for PCa. BBN was employed for actively targeting to gastrin-releasing peptide receptor (GRPR)-overexpressing PCa cells. Furthermore, IONPs served as MRI-assisted imaging, drug carriers and ferroptosis inducers through intracellular Fe²⁺ release and Fenton reaction. The physicochemical properties, drug release behavior, cellular uptake, cytotoxicity, ferroptosis induction, MRI imaging performance, and anti-PCa efficacy were systematically evaluated in vitro and in vivo. Results: BBN-IONPs@DTX exhibited favorable physicochemical stability, efficient DTX loading, and accelerated drug release under acidic conditions. GRPR-mediated targeting significantly enhanced nanoparticle internalization in prostate cancer cells. Compared with free DTX or non-targeted IONPs, BBN-IONPs@DTX significantly inhibited tumor cell proliferation. Mechanistically, the nanoplatform induced excessive intracellular ROS generation, glutathione depletion, mitochondrial membrane depolarization, lipid peroxidation, and GPX4 downregulation, indicating enhanced ferroptosis. In vivo, BBN-IONPs@DTX achieved superior tumor accumulation and significantly suppressed tumor growth. Conclusion: The BBN-IONPs@DTX nanoplatform integrates active GRPR targeting, chemotherapy, and ferroptosis induction into a single therapeutic system, providing an effective strategy for synergistic treatment of PCa.
- Open Access
- 18 September 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102317
Multifunctional nanoplatform as nano-inducer of ferroptosis for targeted recognition and imaging-guided therapy of metastatic prostate cancer
- 18 September 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102317
Open AccessMultifunctional nanoplatform as nano-inducer of ferroptosis for targeted recognition and imaging-guided therapy of metastatic prostate cancer
- Open Access
- 18 August 2021
- Published by Springer Nature in Colloid and Polymer Science
- Vol. 299 (10) , 1653
Correction to: Application of chain transfer agents in the two‑part dispersion polymerization of cross‑linked polymer microspheres
- 18 August 2021
- Published by Springer Nature in Colloid and Polymer Science
- Vol. 299 (10) , 1653
Open AccessCorrection to: Application of chain transfer agents in the two‑part dispersion polymerization of cross‑linked polymer microspheres
- Open Access
- 1 October 2020
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 10011-10015
Most Adult Intussusceptions are Caused by Tumors: A Single-Centre Analysis
Background: Adult intussusception is less common than paediatric intussusception. The aim of this study was to explore the clinical presentation, aetiology, diagnosis and treatment of adult intussusception. Methods: Adults (> 18 years) with intussusception treated by surgical or conservative measures were included from January 2005 to January 2018, and the manifestation, types, diagnosis and treatment of adult intussusception in our centre were reviewed. Results: A total of 150 patients with adult intussusception were included in this study. The clinical manifestations included 111 cases (74%) of abdominal pain, 38 cases (25.3%) of bloody stool, 37 cases (24.7%) of bowel obstructions, 33 cases (22%) of abdominal distension, 29 cases (19.3%) of nausea and vomiting, 19 cases (12.7%) of an abdominal mass, and 12 cases (8.0%) of diarrhoea. The types of intussusception were classified into 36 cases (24%) of enteric intussusception, 87 cases (58%) of intestine-colon intussusception and 27 cases (18%) of colonic intussusception. Surgical intervention was applied in 139 cases (92.7%), including 115 patients who underwent open surgery, and laparoscopy-assisted surgery was performed in 24 patients. The main pathogenesis of intussusception was malignant tumors in 51 cases (36.7%) and benign tumors and polyps in 49 cases (35.3%). Conclusion: Malignant and benign tumors are the main causes of adult intussusception. Abdominal CT is the preferred evaluation method for the preoperative diagnosis of this condition. The choice of surgical procedure depends on the location and type of intussusception.
- 1 October 2020
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 10011-10015
Open AccessMost Adult Intussusceptions are Caused by Tumors: A Single-Centre Analysis
Background: Adult intussusception is less common than paediatric intussusception. The aim of this study was to explore the clinical presentation, aetiology, diagnosis and treatment of adult intussusception. Methods: Adults (> 18 years) with intussusception treated by surgical or conservative measures were included from January 2005 to January 2018, and the manifestation, types, diagnosis and treatment of adult intussusception in our centre were reviewed. Results: A total of 150 patients with adult intussusception were included in this study. The clinical manifestations included 111 cases (74%) of abdominal pain, 38 cases (25.3%) of bloody stool, 37 cases (24.7%) of bowel obstructions, 33 cases (22%) of abdominal distension, 29 cases (19.3%) of nausea and vomiting, 19 cases (12.7%) of an abdominal mass, and 12 cases (8.0%) of diarrhoea. The types of intussusception were classified into 36 cases (24%) of enteric intussusception, 87 cases (58%) of intestine-colon intussusception and 27 cases (18%) of colonic intussusception. Surgical intervention was applied in 139 cases (92.7%), including 115 patients who underwent open surgery, and laparoscopy-assisted surgery was performed in 24 patients. The main pathogenesis of intussusception was malignant tumors in 51 cases (36.7%) and benign tumors and polyps in 49 cases (35.3%). Conclusion: Malignant and benign tumors are the main causes of adult intussusception. Abdominal CT is the preferred evaluation method for the preoperative diagnosis of this condition. The choice of surgical procedure depends on the location and type of intussusception.
- Open Access
- 1 January 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (1)
Bladder mulberry-like fibroepithelial polyp with calcification and squamous cell metaplasia mimicking bladder carcinoma: case report and literature review
Fibroepithelial polyps (FEPs) are a rare, benign disease in the urinary system. We present a clinical case of a 34-year-old woman with a symptomatic bladder tumor. Cystoscopy showed a mulberry-like mass with calcification in the bladder trigone. After transurethral resection, histopathology showed an FEP in the bladder with calcification and squamous cell metaplasia. The patient was discharged from hospital 3 days after surgery. We review the recent literature to summarize the clinical manifestations, treatments, and prognosis of bladder FEPs.
- 1 January 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (1)
Open AccessBladder mulberry-like fibroepithelial polyp with calcification and squamous cell metaplasia mimicking bladder carcinoma: case report and literature review
Fibroepithelial polyps (FEPs) are a rare, benign disease in the urinary system. We present a clinical case of a 34-year-old woman with a symptomatic bladder tumor. Cystoscopy showed a mulberry-like mass with calcification in the bladder trigone. After transurethral resection, histopathology showed an FEP in the bladder with calcification and squamous cell metaplasia. The patient was discharged from hospital 3 days after surgery. We review the recent literature to summarize the clinical manifestations, treatments, and prognosis of bladder FEPs.
- Open Access
- 19 June 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 46 (7) , 2954-2960
Emphysematous pyelonephritis and cystitis: A case report and literature review
This present case report describes a 64-year-old female patient with type 2 diabetes mellitus who also had emphysematous pyelonephritis (EPN) and emphysematous cystitis (EC). Computed tomography revealed well defined emphysematous pyelonephritis and cystitis. Broad-spectrum antibiotic and percutaneous drainage of the right kidney were used as part of a conservative management regimen. The patient achieved clinical recovery and was discharged 12 days after admission. Furthermore, 13 other cases of EPC and EC that were reported between 1962 and 2017 were reviewed and discussed. The overall mortality was 15.4% (two of 13 patients), compared with 25% for EPN alone or 7.4% for EC alone as reported in the literature. The primary pathogen identified in the 13 patients was Escherichia coli (53.8%). All 13 patients were treated with antibiotics.
- 19 June 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 46 (7) , 2954-2960
Open AccessEmphysematous pyelonephritis and cystitis: A case report and literature review
This present case report describes a 64-year-old female patient with type 2 diabetes mellitus who also had emphysematous pyelonephritis (EPN) and emphysematous cystitis (EC). Computed tomography revealed well defined emphysematous pyelonephritis and cystitis. Broad-spectrum antibiotic and percutaneous drainage of the right kidney were used as part of a conservative management regimen. The patient achieved clinical recovery and was discharged 12 days after admission. Furthermore, 13 other cases of EPC and EC that were reported between 1962 and 2017 were reviewed and discussed. The overall mortality was 15.4% (two of 13 patients), compared with 25% for EPN alone or 7.4% for EC alone as reported in the literature. The primary pathogen identified in the 13 patients was Escherichia coli (53.8%). All 13 patients were treated with antibiotics.
- Open Access
- 13 February 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 46 (4) , 1678-1684
Rare symptomatic bladder leiomyoma: case report and literature review
Bladder leiomyoma is a rare, benign tumour of the bladder. We present a clinical case of a 47-year-old asymptomatic woman with symptomatic bladder leiomyoma. Computed tomography showed well-defined bladder leiomyoma in the right posterior bladder wall. After partial cystectomy, pathology findings confirmed leiomyoma of bladder, and the patient achieved clinical recovery in 8 months. We discuss the relevant recent literature of bladder leiomyoma.
- 13 February 2018
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 46 (4) , 1678-1684
Open AccessRare symptomatic bladder leiomyoma: case report and literature review
Bladder leiomyoma is a rare, benign tumour of the bladder. We present a clinical case of a 47-year-old asymptomatic woman with symptomatic bladder leiomyoma. Computed tomography showed well-defined bladder leiomyoma in the right posterior bladder wall. After partial cystectomy, pathology findings confirmed leiomyoma of bladder, and the patient achieved clinical recovery in 8 months. We discuss the relevant recent literature of bladder leiomyoma.